Not surprisingly, the overexpression of IF1 in hepatocarcinomas [20], bladder [21] and stomach [22] carcinomas and in gliomas [23] contributes, by different mechanisms, to cancer recurrence and progression. The gene discussed is ATP5IF1; the disease is central nervous system cancer.